Company profile for Garuda Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Garuda Therapeutics seeks to create a world which eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies. Like bone marrow transplants, our technology could provide potentially ...
Garuda Therapeutics seeks to create a world which eliminates the dependency on donor or patient cells for blood stem cell transplants. Our platform technology for generating off-the-shelf, self-renewing blood stem cells is poised to provide patients with rapid and broad access to consistent, durable, HLA-compatible transgene-free blood stem cell therapies. Like bone marrow transplants, our technology could provide potentially curative therapies for more than 70 diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
215 First St. Suites 340-350 Cambridge, MA 02142
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/05/09/3078206/0/en/Garuda-Therapeutics-Announces-Name-Change-to-Stratus-Therapeutics-to-Reflect-Mission-of-Pioneering-Full-Hematopoietic-System-Renewal.html

GLOBENEWSWIRE
09 May 2025

https://www.globenewswire.com//news-release/2025/03/04/3036380/0/en/Garuda-Therapeutics-Closes-50-Million-Series-A-1-Financing-to-Advance-Off-the-Shelf-Blood-Stem-Cell-Therapies.html

GLOBENEWSWIRE
04 Mar 2025

https://www.globenewswire.com/news-release/2025/03/03/3035519/0/en/Garuda-Therapeutics-Announces-the-Appointment-of-Avanish-Vellanki-as-President-and-Chief-Executive-Officer.html

GLOBENEWSWIRE
03 Mar 2025

https://www.businesswire.com/news/home/20240109596756/en

BUSINESSWIRE
09 Jan 2024

https://www.businesswire.com/news/home/20231025670593/en

BUSINESSWIRE
25 Oct 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty